$WLSS
Welsis Corp.

2024 Q3 Form 10-Q Financial Statement

#000164033424001208 Filed on August 09, 2024

View on sec.gov

Income Statement

Concept 2024 Q3 2024 Q2 2023 Q2
Revenue $0.00 $4.400K
YoY Change -100.0%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $15.69K $10.00K
YoY Change 56.9% 0.0%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $2.000K $10.00K
YoY Change -80.0%
% of Gross Profit
Operating Expenses $15.69K $8.065K
YoY Change 94.52% 32.82%
Operating Profit -$15.69K -$3.665K
YoY Change 328.05% -39.64%
Interest Expense $1.664K $997.00
YoY Change 66.9%
% of Operating Profit
Other Income/Expense, Net -$1.664K -$997.00
YoY Change 66.9%
Pretax Income -$17.35K $0.00
YoY Change -100.0%
Income Tax $0.00
% Of Pretax Income
Net Earnings -$17.35K -$3.665K
YoY Change 373.45% -39.64%
Net Earnings / Revenue -83.3%
Basic Earnings Per Share $0.00
Diluted Earnings Per Share -$0.01 $0.00
COMMON SHARES
Basic Shares Outstanding 2.753M shares 2.753M shares 2.753M shares
Diluted Shares Outstanding 2.753M shares

Balance Sheet

Concept 2024 Q3 2024 Q2 2023 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $0.00
YoY Change
Cash & Equivalents $0.00 $23.46K
Short-Term Investments
Other Short-Term Assets $10.00K
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $0.00 $5.202K
YoY Change -100.0% 217.2%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles $17.33K $25.33K
YoY Change -31.58% -32.15%
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $17.33K $25.33K
YoY Change -31.58% -32.15%
TOTAL ASSETS
Total Short-Term Assets $0.00 $5.202K
Total Long-Term Assets $17.33K $25.33K
Total Assets $17.33K $30.54K
YoY Change -43.24% -21.66%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $10.13K $73.70K
YoY Change -86.26% 20.82%
Accrued Expenses $11.99K $10.00K
YoY Change 19.9%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $22.11K $108.1K
YoY Change -79.55% 37.79%
LONG-TERM LIABILITIES
Long-Term Debt $50.82K $40.00K
YoY Change 27.05% 0.0%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $50.82K $40.00K
YoY Change 27.05% 0.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $22.11K $108.1K
Total Long-Term Liabilities $50.82K $40.00K
Total Liabilities $72.93K $148.1K
YoY Change -50.77% 25.03%
SHAREHOLDERS EQUITY
Retained Earnings -$131.4K -$140.4K
YoY Change -6.4% 72.45%
Common Stock $276.00 $276.00
YoY Change 0.0% 33.98%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$55.60K -$117.6K
YoY Change
Total Liabilities & Shareholders Equity $17.33K $30.54K
YoY Change -43.24% -21.66%

Cashflow Statement

Concept 2024 Q3 2024 Q2 2023 Q2
OPERATING ACTIVITIES
Net Income -$17.35K -$3.665K
YoY Change 373.45% -39.64%
Depreciation, Depletion And Amortization $2.000K $10.00K
YoY Change -80.0%
Cash From Operating Activities $0.00 $50.00K
YoY Change -100.0%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities $0.00
YoY Change
Cash From Investing Activities $0.00
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000 -20.00K
YoY Change -100.0%
NET CHANGE
Cash From Operating Activities 0.000 50.00K
Cash From Investing Activities 0.000
Cash From Financing Activities 0.000 -20.00K
Net Change In Cash 0.000 30.00K
YoY Change -100.0%
FREE CASH FLOW
Cash From Operating Activities $0.00 $50.00K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
9834 usd
CY2024Q2 us-gaap Assets Current
AssetsCurrent
0 usd
CY2023Q3 us-gaap Assets Current
AssetsCurrent
9834 usd
CY2024Q2 us-gaap Assets
Assets
17333 usd
CY2023Q3 us-gaap Assets
Assets
33167 usd
CY2024Q2 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
10126 usd
CY2023Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
75500 usd
CY2024Q2 us-gaap Interest Payable Current
InterestPayableCurrent
11987 usd
CY2023Q3 us-gaap Interest Payable Current
InterestPayableCurrent
8325 usd
CY2024Q2 welsis Accounts Payable Related Party
AccountsPayableRelatedParty
0 usd
CY2024Q2 us-gaap Liabilities Current
LiabilitiesCurrent
22113 usd
CY2023Q3 us-gaap Liabilities Current
LiabilitiesCurrent
111140 usd
CY2024Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-131394 usd
CY2023Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-140753 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
-55599 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
-117973 usd
CY2024Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
17333 usd
CY2023Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
33167 usd
CY2024Q2 us-gaap Revenues
Revenues
0 usd
CY2023Q2 us-gaap Revenues
Revenues
4400 usd
us-gaap Revenues
Revenues
2000 usd
us-gaap Revenues
Revenues
7900 usd
CY2024Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
15688 usd
CY2023Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
7068 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
43979 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
45608 usd
CY2024Q2 us-gaap Operating Expenses
OperatingExpenses
15688 usd
CY2023Q2 us-gaap Operating Expenses
OperatingExpenses
7068 usd
us-gaap Operating Expenses
OperatingExpenses
43979 usd
us-gaap Operating Expenses
OperatingExpenses
45608 usd
CY2024Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-15688 usd
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-2668 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-41979 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-37708 usd
CY2024Q2 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 usd
CY2023Q2 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
55000 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 usd
CY2024Q2 us-gaap Interest Expense
InterestExpense
1664 usd
CY2023Q2 us-gaap Interest Expense
InterestExpense
997 usd
us-gaap Interest Expense
InterestExpense
3662 usd
us-gaap Interest Expense
InterestExpense
2992 usd
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
19128
dei City Area Code
CityAreaCode
212
dei Local Phone Number
LocalPhoneNumber
552-8991
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
true
dei Entity Shell Company
EntityShellCompany
false
CY2024Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
2752667 shares
CY2024Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
0 usd
CY2024Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
17333 usd
CY2023Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
23333 usd
CY2024Q2 us-gaap Assets Noncurrent
AssetsNoncurrent
17333 usd
CY2023Q3 us-gaap Assets Noncurrent
AssetsNoncurrent
23333 usd
CY2023Q3 welsis Accounts Payable Related Party
AccountsPayableRelatedParty
27315 usd
CY2024Q2 us-gaap Convertible Notes Payable
ConvertibleNotesPayable
10819 usd
CY2023Q3 us-gaap Convertible Notes Payable
ConvertibleNotesPayable
0 usd
CY2024Q2 us-gaap Long Term Notes Payable
LongTermNotesPayable
40000 usd
CY2023Q3 us-gaap Long Term Notes Payable
LongTermNotesPayable
40000 usd
CY2024Q2 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
50819 usd
CY2023Q3 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
40000 usd
CY2024Q2 us-gaap Liabilities
Liabilities
72932 usd
CY2023Q3 us-gaap Liabilities
Liabilities
151140 usd
CY2024Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
75000000 shares
CY2024Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2024Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
2752667 shares
CY2024Q2 us-gaap Common Stock Value
CommonStockValue
276 usd
CY2023Q3 us-gaap Common Stock Value
CommonStockValue
276 usd
CY2024Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
75519 usd
CY2023Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
22504 usd
dei Entity Central Index Key
EntityCentralIndexKey
0001887912
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--09-30
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
CY2023Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
75000000 shares
CY2023Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
2752667 shares
CY2024Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
2752667 shares
CY2023Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
2752667 shares
CY2023Q3 welsis Common Stock Par Value Per Share
CommonStockParValuePerShare
0.0001
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2024-06-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
333-261614
dei Entity Registrant Name
EntityRegistrantName
WELSIS CORP.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
WY
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
98-1620699
dei Entity Address Address Line1
EntityAddressAddressLine1
701 E Cathedral Rd.
dei Entity Address Address Line2
EntityAddressAddressLine2
Ste 45 PMB 405
dei Entity Address City Or Town
EntityAddressCityOrTown
Philadelphia
dei Entity Address State Or Province
EntityAddressStateOrProvince
PA
CY2024Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-1664 usd
CY2023Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-997 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
51338 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-2992 usd
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
-17352 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-3665 usd
us-gaap Net Income Loss
NetIncomeLoss
9359 usd
us-gaap Net Income Loss
NetIncomeLoss
-40700 usd
CY2024Q2 welsis Earning Per Share Basic And Diluted
EarningPerShareBasicAndDiluted
-0.01
CY2023Q2 welsis Earning Per Share Basic And Diluted
EarningPerShareBasicAndDiluted
-0.00
welsis Earning Per Share Basic And Diluted
EarningPerShareBasicAndDiluted
0.00
welsis Earning Per Share Basic And Diluted
EarningPerShareBasicAndDiluted
-0.01
CY2024Q2 welsis Weighted Average Number Of Shares Outstanding Basic And Diluted
WeightedAverageNumberOfSharesOutstandingBasicAndDiluted
2752667 shares
CY2023Q2 welsis Weighted Average Number Of Shares Outstanding Basic And Diluted
WeightedAverageNumberOfSharesOutstandingBasicAndDiluted
2752667 shares
welsis Weighted Average Number Of Shares Outstanding Basic And Diluted
WeightedAverageNumberOfSharesOutstandingBasicAndDiluted
2752667 shares
welsis Weighted Average Number Of Shares Outstanding Basic And Diluted
WeightedAverageNumberOfSharesOutstandingBasicAndDiluted
2752667 shares
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
-117973 usd
CY2023Q4 us-gaap Net Income Loss
NetIncomeLoss
-13264 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-131237 usd
CY2024Q1 welsis Forgiveness Of Related Party Loans
ForgivenessOfRelatedPartyLoans
53015 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
39975 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
-38247 usd
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
-17352 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
-55599 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
-76905 usd
CY2022Q4 us-gaap Net Income Loss
NetIncomeLoss
-9211 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-86116 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-27824 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-113940 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-3665 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-117605 usd
us-gaap Profit Loss
ProfitLoss
9359 usd
us-gaap Profit Loss
ProfitLoss
-40700 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
6000 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
6000 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
55000 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
26145 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
5400 usd
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
3662 usd
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
2997 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-9834 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-26303 usd
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
0 usd
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
12802 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
0 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
12802 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-9834 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-13501 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
9834 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
18703 usd
CY2024Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
0 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
5202 usd
us-gaap Interest Paid Net
InterestPaidNet
0 usd
us-gaap Interest Paid Net
InterestPaidNet
0 usd
us-gaap Income Taxes Paid
IncomeTaxesPaid
0 usd
us-gaap Income Taxes Paid
IncomeTaxesPaid
0 usd
welsis Payment Of Operating Expenses By Unaffiliated Party
PaymentOfOperatingExpensesByUnaffiliatedParty
0 usd
welsis Payment Of Operating Expenses By Unaffiliated Party
PaymentOfOperatingExpensesByUnaffiliatedParty
0 usd
welsis Written Off Of Related Party Debts Amount
WrittenOffOfRelatedPartyDebtsAmount
53015 usd
welsis Written Off Of Related Party Debts Amount
WrittenOffOfRelatedPartyDebtsAmount
0 usd
us-gaap Nature Of Operations
NatureOfOperations
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>NOTE 1 - NATURE OF OPERATIONS</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Welsis Corp. (referred as the “Company”, “we”, “our”) was Incorporated in the State of Wyoming and established on August 16, 2021. We are a development-stage company formed to commence operations concerned with the virtual psychological therapy that is also known as teletherapy or telepsychology services. We have developed a full business plan. Our Company provides counselling and psychological services for adolescents (from 14 years) and adults, for men and women, therapy for individuals, couples and families. Also, we plan to provide our services to specific communities, for example to the corporative sector of business in a form of corporate group sessions or individual ones. We have purchased a website and a working prototype of online services mobile platform application known as “Psychologist-24”.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On March 13, 2024, Dusan Zindovic, the previous majority shareholder of Welsis Corp. (the “Company”), entered into a stock purchase agreement for the sale of 2,000,000 shares of Common Stock of the Company to Skywest Pinnacle Limited. The closing of the purchase and sale occurred on April 1, 2024. As a result of the acquisition, Skywest Pinnacle Limited holds approximately 73% of the issued and outstanding shares of Common Stock of the Company, and as such it is able to unilaterally control the election of our board of directors, all matters upon which shareholder approval is required and, ultimately, the direction of our Company. Also effective April 1, 2024, the previous sole officer and director of the company, Dusan Zindovic, resigned his positions with the Company. Upon such resignations, Kwok Boon Kit was appointed as Chief Executive Officer, Treasurer and Secretary, and Director of the Company.</p>
CY2024Q1 welsis Business Of Description
BusinessOfDescription
the previous majority shareholder of Welsis Corp. (the “Company”), entered into a stock purchase agreement for the sale of 2,000,000 shares of Common Stock of the Company to Skywest Pinnacle Limited. The closing of the purchase and sale occurred on April 1, 2024. As a result of the acquisition, Skywest Pinnacle Limited holds approximately 73% of the issued and outstanding shares
us-gaap Use Of Estimates
UseOfEstimates
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date the financial statements and the reported amount of revenues and expenses during the reporting period. Actual results could differ from those estimates.</p>
CY2024Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
0 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
9834 usd
us-gaap Revenues
Revenues
2000 usd
us-gaap Revenues
Revenues
7900 usd
welsis Convertible Note
ConvertibleNote
21638 shares
CY2024Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-131394 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-9834 usd
welsis Amounts Payable To Related Party
AmountsPayableToRelatedParty
14400 usd
CY2024Q2 us-gaap Shares Issued
SharesIssued
40000 shares
welsis Note Payable Muturity Term
NotePayableMuturityTerm
two years
us-gaap Subordinated Borrowing Interest Rate
SubordinatedBorrowingInterestRate
0.10 pure
welsis Default Interest Rate
DefaultInterestRate
0.12 pure
us-gaap Interest Paid
InterestPaid
3662 usd
us-gaap Interest Paid
InterestPaid
2992 usd
CY2024Q2 us-gaap Notes Payable
NotesPayable
40000 usd
CY2024Q2 us-gaap Interest Payable Current
InterestPayableCurrent
11987 usd
CY2023Q3 us-gaap Interest Payable Current
InterestPayableCurrent
8325 usd
CY2024Q2 us-gaap Convertible Notes Payable
ConvertibleNotesPayable
10819 usd
welsis Convertible Note Payable Muturity Term
ConvertibleNotePayableMuturityTerm
six years
welsis Convertible Note Payable Interest Rate
ConvertibleNotePayableInterestRate
0.08 pure
CY2024Q2 us-gaap Preferred Stock Convertible Conversion Price
PreferredStockConvertibleConversionPrice
0.50
CY2024Q2 us-gaap Loans Payable
LoansPayable
55000 usd
CY2024Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
75000000 shares
CY2024Q2 welsis Common Stock Par Value Per Share
CommonStockParValuePerShare
0.0001
CY2024Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
2752667 shares

Files In Submission

Name View Source Status
0001640334-24-001208-index-headers.html Edgar Link pending
0001640334-24-001208-index.html Edgar Link pending
0001640334-24-001208.txt Edgar Link pending
0001640334-24-001208-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Show.js Edgar Link pending
welsis-20240630.xsd Edgar Link pending
welsis_10q.htm Edgar Link pending
welsis_ex311.htm Edgar Link pending
welsis_ex321.htm Edgar Link pending
welsis-20240630_cal.xml Edgar Link unprocessable
welsis-20240630_pre.xml Edgar Link unprocessable
welsis-20240630_def.xml Edgar Link unprocessable
welsis-20240630_lab.xml Edgar Link unprocessable
welsis_10q_htm.xml Edgar Link completed